TL-310
TL-310 is a novel, orally active Taxane analogue. TL-310 can be used in the research of solid tumors[1][2].
Product Specifications
CAS Number
352697-38-2
UNSPSC
12352005
Target
Drug Derivative
Related Pathways
Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Smiles
O=C([C@@H]([C@H](C1=CC=CO1)NC(OCC(C)C)=O)O)O[C@@H]2C(C)=C([C@H](C([C@]3(C)[C@H](C[C@@]([H])(OC4)[C@]4(OC(C)=O)[C@]3([C@@H]([C@@]5(C2)O)OC(C6=CC=CC=C6)=O)[H])O)=O)OC(C7CC7)=O)C5(C)C
Molecular Formula
C45H55NO16
Molecular Weight
865.92
References & Citations
[1]Glasspool R M, et al. A phase I study of a novel taxane, TL310, orally administered every week in patients (pts) with advanced solid tumors. Journal of Clinical Oncology, 2007, 25 (18_suppl) : 2544-2544. |[2]Harris N, et al. Abstract# 5438: Metabolism of the oral taxane TL310 in vitro and in a Phase I study[J]. Cancer Research, 2009, 69 (9_Supplement) : 5438-5438.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
T8050-20N-FITC 100 µL
TLR3 (Toll Like Receptor 3, Toll-like Receptor 3, TLR 3, TLR-3, CD283, CD283 Antigen) (FITC)
Sign In for Pricing
View Details